La Jolla, CA, United States of America

Elsa Sanchez-Lopez

This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2025-2026.


% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Elsa Sanchez-Lopez

Introduction

Elsa Sanchez-Lopez is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of medical research, particularly in the treatment of macrophage-mediated diseases. Her innovative work has led to the development of methods that can potentially transform the way these diseases are treated.

Latest Patents

Sanchez-Lopez holds a patent titled "Methods for treating macrophage-mediated diseases, and methods of identifying agents useful therefore." This patent outlines methods for treating inflammatory diseases and disorders that are mediated by macrophages. Additionally, it includes techniques for screening agents that may be beneficial in these treatments. She has 1 patent to her name.

Career Highlights

Elsa Sanchez-Lopez is affiliated with the University of California, where she conducts her research. Her work is characterized by a strong focus on innovative solutions to complex medical challenges. She has established herself as a key figure in her field, contributing valuable insights and advancements.

Collaborations

Sanchez-Lopez collaborates with notable researchers, including Michael Karin, to further her research initiatives. Their combined expertise enhances the potential impact of their work on the scientific community.

Conclusion

Elsa Sanchez-Lopez is a trailblazer in the realm of medical innovation, with her patent addressing critical health issues. Her contributions are paving the way for new treatments and improving the understanding of macrophage-mediated diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…